Global Travelers Vaccination Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Travelers Vaccination Market Research Report 2024
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
According to Mr Accuracy reports new survey, global Travelers Vaccination market is projected to reach US$ 5563.8 million in 2029, increasing from US$ 3363.3 million in 2022, with the CAGR of 7.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Travelers Vaccination market research.
The travelers vaccination market is driven by the growing trend of international travel and the increasing awareness of the importance of travel vaccinations. As more people travel across borders for leisure, business, or humanitarian reasons, the risk of exposure to infectious diseases in different regions becomes significant. Travelers vaccination provides essential protection against diseases prevalent in specific destinations, such as yellow fever, typhoid, and hepatitis A. The rise in travel-related health risks and the need for pre-travel health consultations contribute to market growth as travelers seek to safeguard their health during their journeys. Moreover, advancements in vaccine formulations and the availability of combination vaccines have improved convenience and compliance for travelers. However, the market also faces challenges, including ensuring timely and appropriate vaccination before travel, as some vaccines require multiple doses over time. Additionally, addressing vaccine accessibility in remote or underserved areas and overcoming vaccine hesitancy among travelers can pose obstacles for comprehensive travel health protection. To succeed, companies must focus on research and development to offer travel-specific vaccine packages, collaborate with travel agencies and healthcare providers to promote travel health education, and address the challenges to meet the increasing demand for effective and tailored protection for travelers.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Travelers Vaccination market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
GSK
Sanofi Pasteur
Merck
Pfizer
CNBG
Serum Institute of India
Biokangtai
PaxVax
Valneva
EuBiologics
United Biotech
Segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Tourists
Students
Workers
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Travelers Vaccination report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
According to Mr Accuracy reports new survey, global Travelers Vaccination market is projected to reach US$ 5563.8 million in 2029, increasing from US$ 3363.3 million in 2022, with the CAGR of 7.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Travelers Vaccination market research.
The travelers vaccination market is driven by the growing trend of international travel and the increasing awareness of the importance of travel vaccinations. As more people travel across borders for leisure, business, or humanitarian reasons, the risk of exposure to infectious diseases in different regions becomes significant. Travelers vaccination provides essential protection against diseases prevalent in specific destinations, such as yellow fever, typhoid, and hepatitis A. The rise in travel-related health risks and the need for pre-travel health consultations contribute to market growth as travelers seek to safeguard their health during their journeys. Moreover, advancements in vaccine formulations and the availability of combination vaccines have improved convenience and compliance for travelers. However, the market also faces challenges, including ensuring timely and appropriate vaccination before travel, as some vaccines require multiple doses over time. Additionally, addressing vaccine accessibility in remote or underserved areas and overcoming vaccine hesitancy among travelers can pose obstacles for comprehensive travel health protection. To succeed, companies must focus on research and development to offer travel-specific vaccine packages, collaborate with travel agencies and healthcare providers to promote travel health education, and address the challenges to meet the increasing demand for effective and tailored protection for travelers.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Travelers Vaccination market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GSK
Sanofi Pasteur
Merck
Pfizer
CNBG
Serum Institute of India
Biokangtai
PaxVax
Valneva
EuBiologics
United Biotech
Segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Segment by Application
Tourists
Students
Workers
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Travelers Vaccination report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices